| 0 |
Paramagnetic Contrast Agent [EPC] |
792 |
0.1905 |
| 1 |
Interleukin-6 Receptor Antagonist [EPC] |
13351 |
0.1766 |
| 2 |
Antirheumatic Agent [EPC] |
13573 |
0.1717 |
| 3 |
Osmotic Diuretic [EPC] |
583 |
0.1638 |
| 4 |
Glycolipid Disialoganglioside-directed Antibody [EPC] |
86 |
0.1596 |
| 5 |
Antidiarrheal [EPC] |
21 |
0.1448 |
| 6 |
Selective T Cell Costimulation Modulator [EPC] |
13196 |
0.1417 |
| 7 |
Aminosalicylate [EPC] |
10969 |
0.1242 |
| 8 |
Pleuromutilin Antibacterial [EPC] |
84 |
0.1181 |
| 9 |
Standardized Chemical Allergen [EPC] |
1282 |
0.1146 |
| 10 |
Interleukin-1 Receptor Antagonist [EPC] |
1070 |
0.1046 |
| 11 |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
4291 |
0.1000 |
| 12 |
Prostacyclin Receptor Agonist [EPC] |
1658 |
0.0991 |
| 13 |
Cannabinoid [EPC] |
678 |
0.0958 |
| 14 |
Folate Analog [EPC] |
4 |
0.0909 |
| 15 |
Partial Opioid Agonist [EPC] |
6690 |
0.0890 |
| 16 |
Prostaglandin E1 Analog [EPC] |
1267 |
0.0874 |
| 17 |
alpha-Hydroxy Acid [EPC] |
98 |
0.0860 |
| 18 |
Vitamin D [EPC] |
15592 |
0.0849 |
| 19 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
8612 |
0.0837 |
| 20 |
Vitamin C [EPC] |
16628 |
0.0823 |
| 21 |
Non-Standardized Animal Skin Allergenic Extract [EPC] |
4 |
0.0816 |
| 22 |
Opioid Agonist [EPC] |
17975 |
0.0805 |
| 23 |
Muscle Relaxant [EPC] |
2664 |
0.0804 |
| 24 |
Folate Analog Metabolic Inhibitor [EPC] |
24984 |
0.0800 |
| 25 |
Vitamin B12 [EPC] |
16126 |
0.0798 |
| 26 |
CD20-directed Cytolytic Antibody [EPC] |
11790 |
0.0760 |
| 27 |
Copper-containing Intrauterine Device [EPC] |
2323 |
0.0759 |
| 28 |
Histamine-1 Receptor Antagonist [EPC] |
2415 |
0.0757 |
| 29 |
Barbiturate [EPC] |
810 |
0.0751 |
| 30 |
Sulfonamide Antibacterial [EPC] |
208 |
0.0742 |
| 31 |
Interleukin-17A Antagonist [EPC] |
9183 |
0.0737 |
| 32 |
Expectorant [EPC] |
9721 |
0.0725 |
| 33 |
Cytochrome P450 3A Inhibitor [EPC] |
3753 |
0.0718 |
| 34 |
Calcitonin [EPC] |
198 |
0.0715 |
| 35 |
gamma-Aminobutyric Acid-ergic Agonist [EPC] |
4656 |
0.0707 |
| 36 |
Vitamin D Analog [EPC] |
252 |
0.0703 |
| 37 |
Parathyroid Hormone Analog [EPC] |
7234 |
0.0693 |
| 38 |
Tissue-nonspecific Alkaline Phosphatase [EPC] |
329 |
0.0691 |
| 39 |
Human Immunoglobulin G [EPC] |
239 |
0.0686 |
| 40 |
Progestin Antagonist [EPC] |
223 |
0.0682 |
| 41 |
Amide Local Anesthetic [EPC] |
3822 |
0.0678 |
| 42 |
B Lymphocyte Stimulator-specific Inhibitor [EPC] |
1038 |
0.0663 |
| 43 |
Methylxanthine [EPC] |
11233 |
0.0657 |
| 44 |
Reducing and Complexing Thiol [EPC] |
110 |
0.0655 |
| 45 |
Stimulant Laxative [EPC] |
593 |
0.0638 |
| 46 |
Nitrofuran Antibacterial [EPC] |
1189 |
0.0636 |
| 47 |
Calcium [EPC] |
6730 |
0.0615 |
| 48 |
RNA Synthetase Inhibitor Antibacterial [EPC] |
456 |
0.0613 |
| 49 |
Sphingosine 1-phosphate Receptor Modulator [EPC] |
2 |
0.0606 |
| 50 |
Pyrethroid [EPC] |
75 |
0.0601 |
| 51 |
Non-Standardized Insect Allergenic Extract [EPC] |
229 |
0.0595 |
| 52 |
Phosphate Binder [EPC] |
6757 |
0.0592 |
| 53 |
Central Nervous System Stimulant [EPC] |
11267 |
0.0592 |
| 54 |
Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] |
381 |
0.0586 |
| 55 |
Tumor Necrosis Factor Blocker [EPC] |
44922 |
0.0585 |
| 56 |
Androgen [EPC] |
2259 |
0.0584 |
| 57 |
Standardized Insect Venom Allergenic Extract [EPC] |
266 |
0.0583 |
| 58 |
Non-Standardized Plant Allergenic Extract [EPC] |
526 |
0.0579 |
| 59 |
Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
1938 |
0.0577 |
| 60 |
Potassium-sparing Diuretic [EPC] |
922 |
0.0576 |
| 61 |
Aluminum Complex [EPC] |
1010 |
0.0575 |
| 62 |
Cholecystokinin Analog [EPC] |
8 |
0.0571 |
| 63 |
Lincosamide Antibacterial [EPC] |
1241 |
0.0571 |
| 64 |
Sclerosing Agent [EPC] |
18 |
0.0570 |
| 65 |
Lymphocyte Growth Factor [EPC] |
48 |
0.0562 |
| 66 |
Vitamin A [EPC] |
276 |
0.0559 |
| 67 |
Progesterone [EPC] |
766 |
0.0559 |
| 68 |
Provitamin D2 Compound [EPC] |
14596 |
0.0556 |
| 69 |
Lead Chelator [EPC] |
3 |
0.0556 |
| 70 |
Omega-3 Fatty Acid [EPC] |
2 |
0.0556 |
| 71 |
Chloride Channel Activator [EPC] |
409 |
0.0555 |
| 72 |
Non-narcotic Antitussive [EPC] |
743 |
0.0544 |
| 73 |
Central alpha-2 Adrenergic Agonist [EPC] |
2414 |
0.0544 |
| 74 |
Non-Standardized Food Allergenic Extract [EPC] |
797 |
0.0542 |
| 75 |
l-Triiodothyronine [EPC] |
2 |
0.0541 |
| 76 |
Thyroid Stimulating Hormone [EPC] |
38 |
0.0538 |
| 77 |
Antiarrhythmic [EPC] |
3456 |
0.0521 |
| 78 |
Pyrimidine Synthesis Inhibitor [EPC] |
1884 |
0.0520 |
| 79 |
Estrogen Receptor Antagonist [EPC] |
1000 |
0.0516 |
| 80 |
Tetracycline-class Drug [EPC] |
2112 |
0.0514 |
| 81 |
Nitrate Vasodilator [EPC] |
3716 |
0.0511 |
| 82 |
Cephalosporin Antibacterial [EPC] |
309 |
0.0506 |
| 83 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
50314 |
0.0504 |
| 84 |
Phosphodiesterase 4 Inhibitor [EPC] |
544 |
0.0492 |
| 85 |
Aromatase Inhibitor [EPC] |
3756 |
0.0491 |
| 86 |
Parathyroid Hormone-Related Peptide Analog [EPC] |
480 |
0.0483 |
| 87 |
Quinolone Antimicrobial [EPC] |
4687 |
0.0480 |
| 88 |
Nitroimidazole Antimicrobial [EPC] |
2384 |
0.0478 |
| 89 |
Angiopoietin-like 3 Inhibitor [EPC] |
1 |
0.0476 |
| 90 |
Interferon alpha [EPC] |
2616 |
0.0462 |
| 91 |
Mucocutaneous Epithelial Cell Growth Factor [EPC] |
17 |
0.0462 |
| 92 |
Antifibrinolytic Agent [EPC] |
273 |
0.0460 |
| 93 |
alpha-Adrenergic Agonist [EPC] |
1984 |
0.0458 |
| 94 |
Benzodiazepine [EPC] |
24939 |
0.0452 |
| 95 |
Ergot Derivative [EPC] |
155 |
0.0450 |
| 96 |
Corticosteroid [EPC] |
39144 |
0.0450 |
| 97 |
Anti-IgE [EPC] |
2180 |
0.0447 |
| 98 |
Thiazide Diuretic [EPC] |
7889 |
0.0447 |
| 99 |
Standardized Animal Hair Allergenic Extract [EPC] |
22 |
0.0437 |
| 100 |
CD52-directed Cytolytic Antibody [EPC] |
679 |
0.0435 |
| 101 |
Adrenocorticotropic Hormone [EPC] |
51 |
0.0435 |
| 102 |
Partial Opioid Agonist/Antagonist [EPC] |
2 |
0.0435 |
| 103 |
Bismuth [EPC] |
183 |
0.0434 |
| 104 |
Alkaloid [EPC] |
835 |
0.0433 |
| 105 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
2963 |
0.0432 |
| 106 |
gamma-Aminobutyric Acid A Receptor Agonist [EPC] |
52 |
0.0431 |
| 107 |
Non-Standardized Chemical Allergen [EPC] |
341 |
0.0429 |
| 108 |
Anti-epileptic Agent [EPC] |
18585 |
0.0425 |
| 109 |
l-Thyroxine [EPC] |
5356 |
0.0424 |
| 110 |
Protease Inhibitor [EPC] |
1657 |
0.0424 |
| 111 |
beta Lactamase Inhibitor [EPC] |
152 |
0.0421 |
| 112 |
Catecholamine [EPC] |
2070 |
0.0420 |
| 113 |
Leukotriene Receptor Antagonist [EPC] |
614 |
0.0416 |
| 114 |
Plasma Volume Expander [EPC] |
19 |
0.0416 |
| 115 |
Interferon beta [EPC] |
7870 |
0.0414 |
| 116 |
Bile Acid Sequestrant [EPC] |
326 |
0.0413 |
| 117 |
Soluble Guanylate Cyclase Stimulator [EPC] |
869 |
0.0411 |
| 118 |
Opioid Antagonist [EPC] |
24 |
0.0410 |
| 119 |
Tubulin Inhibiting Agent [EPC] |
9 |
0.0409 |
| 120 |
Interleukin-12 Antagonist [EPC] |
2648 |
0.0407 |
| 121 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
2432 |
0.0402 |
| 122 |
Interleukin-23 Antagonist [EPC] |
2844 |
0.0400 |
| 123 |
Cardiac Glycoside [EPC] |
2515 |
0.0395 |
| 124 |
Sympathomimetic-like Agent [EPC] |
1058 |
0.0393 |
| 125 |
Macrolide Antimicrobial [EPC] |
2065 |
0.0393 |
| 126 |
Platelet Aggregation Inhibitor [EPC] |
22812 |
0.0393 |
| 127 |
Peroxisome Proliferator Receptor alpha Agonist [EPC] |
2467 |
0.0387 |
| 128 |
Serotonin-3 Receptor Antagonist [EPC] |
3036 |
0.0387 |
| 129 |
Proton Pump Inhibitor [EPC] |
16607 |
0.0386 |
| 130 |
Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] |
65 |
0.0386 |
| 131 |
Vesicular Monoamine Transporter 2 Inhibitor [EPC] |
30 |
0.0385 |
| 132 |
Thiazide-like Diuretic [EPC] |
1150 |
0.0385 |
| 133 |
Purine Antimetabolite [EPC] |
2395 |
0.0383 |
| 134 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
1691 |
0.0382 |
| 135 |
Parenteral Iron Replacement [EPC] |
343 |
0.0382 |
| 136 |
Phenothiazine [EPC] |
728 |
0.0381 |
| 137 |
Somatostatin Analog [EPC] |
141 |
0.0380 |
| 138 |
Serotonin and Norepinephrine Reuptake Inhibitor [EPC] |
66 |
0.0378 |
| 139 |
Sulfone [EPC] |
263 |
0.0373 |
| 140 |
HER2/neu Receptor Antagonist [EPC] |
1810 |
0.0372 |
| 141 |
beta-Adrenergic Blocker [EPC] |
8545 |
0.0371 |
| 142 |
Interleukin-5 Antagonist [EPC] |
796 |
0.0371 |
| 143 |
Osmotic Laxative [EPC] |
5876 |
0.0367 |
| 144 |
Progestin [EPC] |
8629 |
0.0367 |
| 145 |
Estrogen [EPC] |
5483 |
0.0361 |
| 146 |
Blood Viscosity Reducer [EPC] |
105 |
0.0361 |
| 147 |
Polyene Antifungal [EPC] |
1117 |
0.0358 |
| 148 |
Cholinergic Muscarinic Antagonist [EPC] |
1084 |
0.0358 |
| 149 |
HMG-CoA Reductase Inhibitor [EPC] |
11760 |
0.0358 |
| 150 |
Interleukin-17 Receptor A Antagonist [EPC] |
29 |
0.0358 |
| 151 |
Prostacycline Vasodilator [EPC] |
3219 |
0.0356 |
| 152 |
Dihydrofolate Reductase Inhibitor Antimalarial [EPC] |
31 |
0.0355 |
| 153 |
RANK Ligand Inhibitor [EPC] |
5614 |
0.0350 |
| 154 |
Iron Chelator [EPC] |
878 |
0.0350 |
| 155 |
Anticholinergic [EPC] |
429 |
0.0346 |
| 156 |
Poly(ADP-Ribose) Polymerase Inhibitor [EPC] |
735 |
0.0344 |
| 157 |
Dihydropyridine Calcium Channel Blocker [EPC] |
7933 |
0.0343 |
| 158 |
Loop Diuretic [EPC] |
11497 |
0.0341 |
| 159 |
Non-Standardized Fungal Allergenic Extract [EPC] |
38 |
0.0328 |
| 160 |
mu-Opioid Receptor Agonist [EPC] |
80 |
0.0326 |
| 161 |
CCR5 Co-receptor Antagonist [EPC] |
62 |
0.0325 |
| 162 |
alpha-Adrenergic Blocker [EPC] |
3512 |
0.0325 |
| 163 |
Vitamin D3 Analog [EPC] |
584 |
0.0323 |
| 164 |
Inactivated Influenza B Virus Vaccine [EPC] |
2 |
0.0323 |
| 165 |
Interferon gamma [EPC] |
41 |
0.0322 |
| 166 |
Influenza A M2 Protein Inhibitor [EPC] |
318 |
0.0321 |
| 167 |
Sulfonylurea [EPC] |
3953 |
0.0319 |
| 168 |
Phosphodiesterase 5 Inhibitor [EPC] |
3066 |
0.0319 |
| 169 |
Azole Antifungal [EPC] |
3431 |
0.0318 |
| 170 |
Guanylate Cyclase-C Agonist [EPC] |
559 |
0.0316 |
| 171 |
Glycopeptide Antibacterial [EPC] |
1360 |
0.0315 |
| 172 |
Nucleoside Analog Antiviral [EPC] |
2862 |
0.0315 |
| 173 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
3480 |
0.0314 |
| 174 |
Cyclooxygenase Inhibitor [EPC] |
2 |
0.0312 |
| 175 |
Thyroid Hormone Synthesis Inhibitor [EPC] |
167 |
0.0311 |
| 176 |
Vitamin K [EPC] |
193 |
0.0311 |
| 177 |
Integrin Receptor Antagonist [EPC] |
6338 |
0.0311 |
| 178 |
Antimalarial [EPC] |
183 |
0.0310 |
| 179 |
Aldosterone Antagonist [EPC] |
3211 |
0.0310 |
| 180 |
Nitrogen Binding Agent [EPC] |
2 |
0.0308 |
| 181 |
Endoglycosidase [EPC] |
45 |
0.0307 |
| 182 |
Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] |
208 |
0.0306 |
| 183 |
Interferon alfa-2b [EPC] |
1 |
0.0303 |
| 184 |
Calcitonin Gene-related Peptide Receptor Antagonist [EPC] |
32 |
0.0301 |
| 185 |
Microtubule Inhibitor [EPC] |
3107 |
0.0300 |
| 186 |
General Anesthetic [EPC] |
889 |
0.0295 |
| 187 |
Catecholamine Synthesis Inhibitor [EPC] |
1 |
0.0294 |
| 188 |
Lysosomal beta Glucuronidase [EPC] |
1 |
0.0294 |
| 189 |
PCSK9 Inhibitor [EPC] |
3087 |
0.0292 |
| 190 |
Endothelin Receptor Antagonist [EPC] |
4439 |
0.0291 |
| 191 |
Potassium Channel Blocker [EPC] |
1902 |
0.0291 |
| 192 |
Oxytocic [EPC] |
59 |
0.0290 |
| 193 |
Tricyclic Antidepressant [EPC] |
11 |
0.0289 |
| 194 |
Antiseptic [EPC] |
89 |
0.0288 |
| 195 |
Streptogramin Antibacterial [EPC] |
3 |
0.0288 |
| 196 |
CD4-directed Blocking Antibody [EPC] |
7 |
0.0286 |
| 197 |
Cytolytic Agent [EPC] |
50 |
0.0285 |
| 198 |
Phenylalanine Metabolizing Enzyme [EPC] |
99 |
0.0283 |
| 199 |
Phosphodiesterase 3 Inhibitor [EPC] |
132 |
0.0282 |
| 200 |
Plasma Kallikrein Inhibitor [EPC] |
76 |
0.0282 |
| 201 |
Antiprotozoal [EPC] |
220 |
0.0281 |
| 202 |
Vitamin B6 Analog [EPC] |
6 |
0.0280 |
| 203 |
Uric Acid-specific Enzyme [EPC] |
43 |
0.0280 |
| 204 |
Androgen Receptor Inhibitor [EPC] |
1642 |
0.0278 |
| 205 |
Complement Inhibitor [EPC] |
1255 |
0.0278 |
| 206 |
Angiotensin 2 Receptor Blocker [EPC] |
6609 |
0.0277 |
| 207 |
Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] |
337 |
0.0277 |
| 208 |
5-Lipoxygenase Inhibitor [EPC] |
14 |
0.0276 |
| 209 |
Kinase Inhibitor [EPC] |
9573 |
0.0276 |
| 210 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
2072 |
0.0274 |
| 211 |
Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] |
149 |
0.0273 |
| 212 |
Antihypoglycemic Agent [EPC] |
69 |
0.0273 |
| 213 |
Nicotinic Acid [EPC] |
1178 |
0.0266 |
| 214 |
Histamine-2 Receptor Antagonist [EPC] |
7209 |
0.0266 |
| 215 |
Substance P/Neurokinin-1 Receptor Antagonist [EPC] |
362 |
0.0263 |
| 216 |
Xanthine Oxidase Inhibitor [EPC] |
3301 |
0.0260 |
| 217 |
Anthelmintic [EPC] |
54 |
0.0258 |
| 218 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
1976 |
0.0256 |
| 219 |
Radioactive Diagnostic Agent [EPC] |
28 |
0.0254 |
| 220 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
1908 |
0.0253 |
| 221 |
Gonadotropin [EPC] |
29 |
0.0253 |
| 222 |
Mood Stabilizer [EPC] |
4136 |
0.0249 |
| 223 |
5-alpha Reductase Inhibitor [EPC] |
1367 |
0.0249 |
| 224 |
Monobactam Antibacterial [EPC] |
48 |
0.0248 |
| 225 |
Antiparasitic [EPC] |
102 |
0.0247 |
| 226 |
Pediculicide [EPC] |
104 |
0.0245 |
| 227 |
Janus Kinase Inhibitor [EPC] |
1071 |
0.0244 |
| 228 |
beta3-Adrenergic Agonist [EPC] |
598 |
0.0244 |
| 229 |
Calcitonin Gene-related Peptide Antagonist [EPC] |
21 |
0.0241 |
| 230 |
Rifamycin Antimycobacterial [EPC] |
51 |
0.0239 |
| 231 |
Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] |
27 |
0.0238 |
| 232 |
Skin Test Antigen [EPC] |
46 |
0.0234 |
| 233 |
Leukocyte Growth Factor [EPC] |
2323 |
0.0234 |
| 234 |
GLP-2 Analog [EPC] |
166 |
0.0233 |
| 235 |
Bile Acid [EPC] |
266 |
0.0233 |
| 236 |
Benzodiazepine Antagonist [EPC] |
13 |
0.0232 |
| 237 |
Insulin [EPC] |
1024 |
0.0232 |
| 238 |
Erythropoiesis-stimulating Agent [EPC] |
1645 |
0.0230 |
| 239 |
Leptin Analog [EPC] |
17 |
0.0228 |
| 240 |
Insulin Analog [EPC] |
8100 |
0.0227 |
| 241 |
Acetylcholine Release Inhibitor [EPC] |
1476 |
0.0227 |
| 242 |
Contrast Agent for Ultrasound Imaging [EPC] |
82 |
0.0226 |
| 243 |
Hedgehog Pathway Inhibitor [EPC] |
160 |
0.0225 |
| 244 |
Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] |
12 |
0.0225 |
| 245 |
Antidote [EPC] |
180 |
0.0223 |
| 246 |
Gonadotropin Releasing Hormone Receptor Antagonist [EPC] |
21 |
0.0223 |
| 247 |
Ester Local Anesthetic [EPC] |
9 |
0.0222 |
| 248 |
Aromatic Amino Acid Decarboxylation Inhibitor [EPC] |
872 |
0.0221 |
| 249 |
Carbonic Anhydrase Inhibitor [EPC] |
325 |
0.0221 |
| 250 |
Gadolinium-based Contrast Agent [EPC] |
76 |
0.0219 |
| 251 |
Oxaborole Antifungal [EPC] |
16 |
0.0219 |
| 252 |
P2Y12 Platelet Inhibitor [EPC] |
515 |
0.0219 |
| 253 |
Interferon gamma Blocker [EPC] |
1 |
0.0217 |
| 254 |
Urease Inhibitor [EPC] |
1 |
0.0217 |
| 255 |
Farnesyltransferase Inhibitor [EPC] |
1 |
0.0217 |
| 256 |
Catechol-O-Methyltransferase Inhibitor [EPC] |
222 |
0.0214 |
| 257 |
Aromatic Amino Acid [EPC] |
952 |
0.0214 |
| 258 |
Melanin Synthesis Inhibitor [EPC] |
34 |
0.0213 |
| 259 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
2043 |
0.0210 |
| 260 |
Parathyroid Hormone [EPC] |
86 |
0.0206 |
| 261 |
Adenosine Receptor Agonist [EPC] |
115 |
0.0205 |
| 262 |
Vitamin D2 Analog [EPC] |
302 |
0.0205 |
| 263 |
Rifamycin Antibacterial [EPC] |
394 |
0.0203 |
| 264 |
Glucosylceramide Synthase Inhibitor [EPC] |
32 |
0.0202 |
| 265 |
Radiographic Contrast Agent [EPC] |
329 |
0.0200 |
| 266 |
Human Platelet-derived Growth Factor [EPC] |
41 |
0.0195 |
| 267 |
Non-Standardized Pollen Allergenic Extract [EPC] |
7 |
0.0192 |
| 268 |
Platinum-based Drug [EPC] |
3120 |
0.0190 |
| 269 |
Interleukin-6 Antagonist [EPC] |
5 |
0.0190 |
| 270 |
Sigma-1 Agonist [EPC] |
49 |
0.0190 |
| 271 |
Antisense Oligonucleotide [EPC] |
110 |
0.0188 |
| 272 |
Prostaglandin Analog [EPC] |
1325 |
0.0184 |
| 273 |
Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] |
260 |
0.0183 |
| 274 |
Cytomegalovirus pUL97 Kinase Inhibitor [EPC] |
1 |
0.0182 |
| 275 |
Recombinant Human Growth Hormone [EPC] |
202 |
0.0181 |
| 276 |
Aldehyde Dehydrogenase Inhibitor [EPC] |
13 |
0.0181 |
| 277 |
Nucleoside Metabolic Inhibitor [EPC] |
3562 |
0.0181 |
| 278 |
Intestinal Lipase Inhibitor [EPC] |
442 |
0.0180 |
| 279 |
Glinide [EPC] |
150 |
0.0180 |
| 280 |
Adrenal Steroid Synthesis Inhibitor [EPC] |
8 |
0.0179 |
| 281 |
Monoamine Oxidase Inhibitor [EPC] |
44 |
0.0178 |
| 282 |
Prostacycline [EPC] |
167 |
0.0177 |
| 283 |
Dipeptidyl Peptidase 4 Inhibitor [EPC] |
243 |
0.0176 |
| 284 |
Sucrose-specific Enzyme [EPC] |
1 |
0.0175 |
| 285 |
Methylating Agent [EPC] |
13 |
0.0172 |
| 286 |
4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] |
13 |
0.0172 |
| 287 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
2251 |
0.0172 |
| 288 |
Cholinergic Receptor Agonist [EPC] |
36 |
0.0172 |
| 289 |
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] |
842 |
0.0171 |
| 290 |
Chemokine Receptor Type 4 Interaction [EPC] |
11 |
0.0171 |
| 291 |
Hepatitis C Virus NS5A Inhibitor [EPC] |
725 |
0.0167 |
| 292 |
Farnesoid X Receptor Agonist [EPC] |
91 |
0.0166 |
| 293 |
Anti-coagulant [EPC] |
88 |
0.0166 |
| 294 |
Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC] |
2 |
0.0165 |
| 295 |
Lipoglycopeptide Antibacterial [EPC] |
12 |
0.0165 |
| 296 |
Factor Xa Inhibitor [EPC] |
5123 |
0.0160 |
| 297 |
Antimycobacterial [EPC] |
224 |
0.0158 |
| 298 |
Melatonin Receptor Agonist [EPC] |
160 |
0.0156 |
| 299 |
Proteasome Inhibitor [EPC] |
1241 |
0.0156 |
| 300 |
Anti-anginal [EPC] |
254 |
0.0154 |
| 301 |
Photoactivated Radical Generator [EPC] |
8 |
0.0151 |
| 302 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
1614 |
0.0150 |
| 303 |
Aminoglycoside Antibacterial [EPC] |
453 |
0.0149 |
| 304 |
Histone Deacetylase Inhibitor [EPC] |
37 |
0.0149 |
| 305 |
Cholinesterase Inhibitor [EPC] |
202 |
0.0148 |
| 306 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
445 |
0.0148 |
| 307 |
GLP-1 Receptor Agonist [EPC] |
2704 |
0.0144 |
| 308 |
Atypical Antipsychotic [EPC] |
5012 |
0.0143 |
| 309 |
CD33-directed Immunoconjugate [EPC] |
41 |
0.0142 |
| 310 |
Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] |
19 |
0.0141 |
| 311 |
Actinomycin [EPC] |
30 |
0.0141 |
| 312 |
Thrombopoietin Receptor Agonist [EPC] |
165 |
0.0141 |
| 313 |
Carnitine Analog [EPC] |
27 |
0.0139 |
| 314 |
Cholinergic Nicotinic Agonist [EPC] |
711 |
0.0136 |
| 315 |
Antileishmanial [EPC] |
3 |
0.0135 |
| 316 |
Estrogen Agonist/Antagonist [EPC] |
34 |
0.0135 |
| 317 |
Alkylating Drug [EPC] |
2236 |
0.0135 |
| 318 |
Epidermal Growth Factor Receptor Antagonist [EPC] |
474 |
0.0132 |
| 319 |
Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] |
129 |
0.0132 |
| 320 |
Pyridone [EPC] |
379 |
0.0130 |
| 321 |
Typical Antipsychotic [EPC] |
236 |
0.0130 |
| 322 |
Human Immunoglobulin [EPC] |
1 |
0.0130 |
| 323 |
Thalidomide Analog [EPC] |
4459 |
0.0126 |
| 324 |
CD38-directed Cytolytic Antibody [EPC] |
259 |
0.0126 |
| 325 |
Lipid Emulsion [EPC] |
20 |
0.0125 |
| 326 |
Potassium Binder [EPC] |
163 |
0.0121 |
| 327 |
BCL-2 Inhibitor [EPC] |
295 |
0.0118 |
| 328 |
Dopamine-2 Receptor Antagonist [EPC] |
56 |
0.0118 |
| 329 |
alpha-Glucosidase Inhibitor [EPC] |
41 |
0.0117 |
| 330 |
CTLA-4-directed Blocking Antibody [EPC] |
337 |
0.0117 |
| 331 |
Antimetabolite Immunosuppressant [EPC] |
100 |
0.0115 |
| 332 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
141 |
0.0108 |
| 333 |
Lipid-based Polyene Antifungal [EPC] |
124 |
0.0107 |
| 334 |
Orexin Receptor Antagonist [EPC] |
119 |
0.0106 |
| 335 |
Asparagine-specific Enzyme [EPC] |
97 |
0.0106 |
| 336 |
CD123 Interaction [EPC] |
2 |
0.0106 |
| 337 |
Hematopoietic Stem Cell Mobilizer [EPC] |
11 |
0.0105 |
| 338 |
Oxazolidinone Antibacterial [EPC] |
194 |
0.0104 |
| 339 |
Topoisomerase Inhibitor [EPC] |
489 |
0.0103 |
| 340 |
Polymyxin-class Antibacterial [EPC] |
8 |
0.0103 |
| 341 |
SLAMF7-directed Immunostimulatory Antibody [EPC] |
41 |
0.0100 |
| 342 |
CD30-directed Immunoconjugate [EPC] |
56 |
0.0098 |
| 343 |
Echinocandin Antifungal [EPC] |
45 |
0.0095 |
| 344 |
Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] |
10 |
0.0092 |
| 345 |
Macrolide Antibacterial [EPC] |
14 |
0.0091 |
| 346 |
Lipopeptide Antibacterial [EPC] |
88 |
0.0088 |
| 347 |
Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] |
36 |
0.0086 |
| 348 |
Immunoglobulin G [EPC] |
50 |
0.0083 |
| 349 |
CD22-directed Immunoconjugate [EPC] |
13 |
0.0081 |
| 350 |
Recombinant Human Deoxyribonuclease 1 [EPC] |
126 |
0.0080 |
| 351 |
Arteriolar Vasodilator [EPC] |
177 |
0.0077 |
| 352 |
Photoenhancer [EPC] |
11 |
0.0076 |
| 353 |
Neuraminidase Inhibitor [EPC] |
19 |
0.0074 |
| 354 |
Benzothiazole [EPC] |
12 |
0.0072 |
| 355 |
Recombinant Human Nerve Growth Factor [EPC] |
16 |
0.0072 |
| 356 |
Programmed Death Ligand-1 Blocker [EPC] |
56 |
0.0071 |
| 357 |
Vasopressin V2 Receptor Antagonist [EPC] |
52 |
0.0067 |
| 358 |
Hydrolytic Lysosomal Cholesteryl Ester-specific Enzyme [EPC] |
3 |
0.0066 |
| 359 |
Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] |
27 |
0.0066 |
| 360 |
Interleukin-2 Receptor Blocking Antibody [EPC] |
51 |
0.0066 |
| 361 |
Polyene Antimicrobial [EPC] |
1 |
0.0060 |
| 362 |
Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] |
78 |
0.0059 |
| 363 |
Anthracycline Topoisomerase Inhibitor [EPC] |
4 |
0.0058 |
| 364 |
Retinoid [EPC] |
1200 |
0.0056 |
| 365 |
Nucleoside Analog Antifungal [EPC] |
4 |
0.0055 |
| 366 |
Tetracycline-class Antibacterial [EPC] |
19 |
0.0045 |
| 367 |
Human Blood Coagulation Factor [EPC] |
1 |
0.0042 |
| 368 |
Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] |
49 |
0.0042 |
| 369 |
Penem Antibacterial [EPC] |
5 |
0.0039 |
| 370 |
SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] |
28 |
0.0039 |
| 371 |
Selective T Cell Costimulation Blocker [EPC] |
8 |
0.0029 |
| 372 |
Carbamoyl Phosphate Synthetase 1 Activator [EPC] |
1 |
0.0024 |
| 373 |
Surfactant [EPC] |
2 |
0.0021 |